IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, Z. L.
Right arrow Articles by Kozel, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, Z. L.
Right arrow Articles by Kozel, T. R.
Infection and Immunity, January 2006, p. 144-151, Vol. 74, No. 1
0019-9567/06/$08.00+0     doi:10.1128/IAI.74.1.144-151.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Binding and Internalization of Glucuronoxylomannan, the Major Capsular Polysaccharide of Cryptococcus neoformans, by Murine Peritoneal Macrophages

Zong Liang Chang,1,2 Dale Netski,1,{dagger} Peter Thorkildson,1 and Thomas R. Kozel1*

Department of Microbiology and Immunology, University of Nevada School of Medicine, Reno, Nevada 89557,1 Laboratory of Immune Signal Transduction, Institute of Biochemistry and Cell Biology, Shanghai Institute of Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China2

Received 26 August 2005/ Returned for modification 29 September 2005/ Accepted 26 October 2005

Glucuronoxylomannan (GXM), the major component of the capsular polysaccharide of Cryptococcus neoformans, is essential to virulence of the yeast. Previous studies found that the interaction between GXM and phagocytic cells has biological consequences that may contribute to the pathogenesis of cryptococcosis. We found that GXM binds to and is taken up by murine peritoneal macrophages. Uptake is dose and time dependent. Examination of the sites of GXM accumulation by immunofluorescence microscopy showed that the pattern was discontinuous and punctate both on the surfaces of macrophages and at intracellular depots. Although resident macrophages showed appreciable accumulation of GXM, uptake was greatest with thioglycolate-elicited macrophages. A modest stimulation of GXM binding followed treatment of resident macrophages with phorbol 12-myristate 13-acetate, but treatment with lipopolysaccharide or gamma interferon alone or in combination had no effect. Accumulation of GXM was critically dependent on cytoskeleton function; a near complete blockade of accumulation followed treatment with inhibitors of actin. GXM accumulation by elicited macrophages was blocked by treatment with inhibitors of tyrosine kinase, protein kinase C, and phospholipase C, but not by inhibitors of phosphatidylinositol 3-kinase, suggesting a critical role for one or more signaling pathways in the macrophage response to GXM. Taken together, the results demonstrate that it is possible to experimentally enhance or suppress binding of GXM to macrophages, raising the possibility for regulation of the interaction between this essential virulence factor and binding sites on cells that are central to host resistance.


* Corresponding author. Mailing address: Department of Microbiology and Immunology/320, School of Medicine, University of Nevada, Reno, NV 89557. Phone: (775) 784-4124. Fax: (775) 327-2332. E-mail: trkozel{at}med.unr.edu.

Editor: A. Casadevall

{dagger} Present address: Division of Infectious Diseases, John's Hopkins University School of Medicine, 424 N. Bond St., Room 104, Baltimore, MD 21205.


Infection and Immunity, January 2006, p. 144-151, Vol. 74, No. 1
0019-9567/06/$08.00+0     doi:10.1128/IAI.74.1.144-151.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2006 by the American Society for Microbiology. All rights reserved.